PKM2 Is the Target of a Multi-Herb-Combined Decoction During the Inhibition of Gastric Cancer Progression
Gastric cancer is the third leading cause of cancer death worldwide. Traditional Chinese medicine (TCM) is increasingly extensively applied as a complementary therapy for gastric cancer (GC) in China, which shows unique advantages in preventing gastric cancer metastasis. Previous study indicates mod...
Guardado en:
Autores principales: | Qingmin Sun, Mengyun Yuan, Hongxing Wang, Xingxing Zhang, Ruijuan Zhang, Haidan Wang, Xu Chen, Min Zhu, Shenlin Liu, Jian Wu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/70cf44ee81a641ff9899aba70027aa18 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Deubiquitinase PSMD14 promotes ovarian cancer progression by decreasing enzymatic activity of PKM2
por: Tianshui Sun, et al.
Publicado: (2021) -
Iridin Prevented Against Lipopolysaccharide-Induced Inflammatory Responses of Macrophages via Inactivation of PKM2-Mediated Glycolytic Pathways
por: Ying ZH, et al.
Publicado: (2021) -
MiR-489-3p Reduced Pancreatic Cancer Proliferation and Metastasis By Targeting PKM2 and LDHA Involving Glycolysis
por: Dan Zhang, et al.
Publicado: (2021) -
NOX4-derived ROS-induced overexpression of FOXM1 regulates aerobic glycolysis in glioblastoma
por: Xiangsheng Su, et al.
Publicado: (2021) -
Mir-26b inhibits growth and resistance to paclitaxel chemotherapy by silencing the CDC6 gene in gastric cancer
por: Bochao Zhao, et al.
Publicado: (2019)